Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-15

Clinical Trial Update: Effect of Konjac-mannan in Individuals With Insulin-Resistance Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating konjac-mannan in individuals with insulin resistance syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • konjac-mannan

Snippet

Sponsor: Unity Health Toronto | Conditions: Insulin Resistance Syndrome | Phase 2 | Status: COMPLETED